DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation

This publication has 43 references indexed in Scilit:

• Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine
  Clinical Immunology, 2004
• The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guerin) in protecting against systemic Mycobacterim avium infection
  Immunology, 2003
• Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis
  Gene Therapy, 2003
• Induction of a Systemic Immune Response by a Polyvalent Melanoma-Associated Antigen DNA Vaccine for Prevention and Treatment of Malignant Melanoma
  Molecular Therapy, 2002
• Immunology of Tuberculosis
  Annual Review of Immunology, 2001
• Safety Evaluation of Hemagglutinating Virus of Japan–Artificial Viral Envelope Liposomes in Nonhuman Primates
  Human Gene Therapy, 2001
• Direct Immunization of Malaria DNA Vaccine into the Liver by Gene Gun Protects against Lethal Challenge of Plasmodium berghei Sporozoite
  Biochemical and Biophysical Research Communications, 2000
• Development and Characterization of Cationic Liposomes Conjugated with HVJ (Sendai Virus): Reciprocal Effect of Cationic Lipid forIn VitroandIn VivoGene Transfer
  Human Gene Therapy, 1997
• Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo
  Nature Biotechnology, 1997
• B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation.
  The Journal of Experimental Medicine, 1983